genXone S.A.

zł 4.50As of Sun 8 Nov 2026, 12:00 UTC
WSE:GX1Healthcare
Country Poland
PE (Fwd) •••
TSR 6Y CAGR (27.58%)
Div yield —
ROE (25.20%)
Biotechnology
Beta (5Y) (0.28)
PE TTM —
TSR TTM (15.73%)
Mkt cap zł 14.87M
ROIC (38.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
zł 4.32
(4.07%)
(71.50%)
Hold 9|11|10|2|10
4Q25
1Q26
2Q26
3Q26
Earnings per sharezł
0.07
0.07
0.08
0.08
16.16%
19.33%
15.39%
24.54%
Revenuezł M
1.945
1.913
2.023
2.093
13.66%
7.35%
12.34%
12.01%
Peers (US$3.756M)
Cap (US$)
PE
14.53M
112.3x
7.876M
—
3.721M
—
Capital
TTM
5Y
10Y
Leveragex
1.075
0.052
0.047
EBIT/Intx
0.318
0.751
0.836
Own earn%
25.61
(53.27)
(46.78)
Sh yield%
9.87
26.82
18.90
Owners
Insiders/Inst%
11.79
84.33
Short interest%
3.72
SBC / revenue%
0.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
16–20
$1 testx
—
Incr. ROIC%
2